IVAX – Framingham Source

Alzheon Appoints Former IVAX President as Vice Chair of Board

August 9, 2018August 10, 2018 Framingham Source Editor Susan Petroni 0 Comments Alzheon, biopharmaceutical company, Board of Directors, Inc., IVAX, Neil Flanzraich

FRAMINGHAM – Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and other neurological